ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS
· Delayed Price · Currency is USD
0.211
-0.001 (-0.59%)
At close: Apr 28, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.71 million as of April 29, 2026. Its market cap has decreased by -13.51% in one year.
Market Cap
1.71M
Enterprise Value
1.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.21
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 1.71M, a decrease of -98.21%. That is a compound annual growth rate of -61.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.71M | 58.12% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agentix | 1.76M |
| Clearside Biomedical | 1.62M |
| Enzolytics | 1.93M |
| inTerra Resources | 1.47M |
| Protagenic Therapeutics | 1.47M |
| Neon Bloom | 1.46M |
| Avenue Therapeutics | 2.17M |
| ProtoKinetix | 2.21M |